AADI Insider Trading Activity and SEC Form 4 Filings
AADI insider trading summary
No open-market insider purchases or sales of Aadi Bioscience, Inc. (AADI) have been reported on SEC Form 4 in the past 12 months.
Latest AADI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 3, 2025 | Bryan Ball | See remarks | Sell | $5K (2,147 @ $2.35) |
| Mar 3, 2025 | Scott M. Giacobello | Chief Financial Officer | Sell | $7K (2,806 @ $2.35) |
| Mar 3, 2025 | David James Lennon | Chief Executive Officer | Sell | $13K (5,690 @ $2.35) |
| Oct 3, 2024 | David James Lennon | Chief Executive Officer | Sell | $19K (9,689 @ $1.94) |
| Sep 3, 2024 | Neil Desai | Executive Chairman | Sell | $68K (40,000 @ $1.71) |
| Aug 5, 2024 | Neil Desai | Executive Chairman | Sell | $8K (5,652 @ $1.34) |
| Aug 2, 2024 | Neil Desai | Executive Chairman | Sell | $27K (18,933 @ $1.41) |
| Aug 1, 2024 | Neil Desai | Executive Chairman | Sell | $23K (15,415 @ $1.50) |
| Jul 2, 2024 | Neil Desai | Executive Chairman | Sell | $12K (8,652 @ $1.34) |
| Jul 1, 2024 | Neil Desai | Executive Chairman | Sell | $46K (31,348 @ $1.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.